ArticleNature medicine2016

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Elisa M Noll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.